Prudential Financial Inc. cut its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 21.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 313,090 shares of the medical instruments supplier’s stock after selling 87,180 shares during the quarter. Prudential Financial Inc. owned about 0.42% of West Pharmaceutical Services worth $30,138,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of WST. Acrospire Investment Management LLC acquired a new position in West Pharmaceutical Services during the second quarter worth about $113,000. Citigroup Inc. boosted its holdings in West Pharmaceutical Services by 95.1% in the 2nd quarter. Citigroup Inc. now owns 1,569 shares of the medical instruments supplier’s stock valued at $148,000 after purchasing an additional 765 shares during the last quarter. Wolverine Trading LLC acquired a new position in West Pharmaceutical Services in the 2nd quarter valued at about $200,000. Nomura Holdings Inc. acquired a new position in West Pharmaceutical Services in the 2nd quarter valued at about $201,000. Finally, Bradley Foster & Sargent Inc. CT acquired a new position in West Pharmaceutical Services in the 2nd quarter valued at about $212,000. Hedge funds and other institutional investors own 91.02% of the company’s stock.

Several equities analysts have weighed in on the stock. lowered shares of West Pharmaceutical Services from a “sell” rating to a “strong sell” rating in a report on Thursday, August 3rd. assumed coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 target price on the stock. lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a report on Wednesday, July 19th. Wells Fargo & Company boosted their target price on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Finally, Bank of America Corporation lowered shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 target price on the stock. in a report on Tuesday, October 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $106.00.

Shares of West Pharmaceutical Services, Inc. (WST) opened at $100.85 on Wednesday. The stock has a market cap of $7,546.32, a P/E ratio of 43.81, a PEG ratio of 2.17 and a beta of 1.14. West Pharmaceutical Services, Inc. has a 52 week low of $76.89 and a 52 week high of $103.36. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.14. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The firm had revenue of $398.20 million for the quarter, compared to the consensus estimate of $386.02 million. During the same period in the prior year, the firm earned $0.53 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. sell-side analysts anticipate that West Pharmaceutical Services, Inc. will post 2.76 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/11/15/prudential-financial-inc-sells-87180-shares-of-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.